Four out of the five candidate genes CCDC115, DNAJC10, RNF149 and STYXL1, demonstrated significantly differential expression between normal and prostate adenocarcinoma tissue in humans (Fig. 4a). Here, RNF149 is linked to prostate adenocarcinoma.